PD-1 inhibitors-associated myocarditis in non-small cell lung cancer patients

BACKGROUND: Immune checkpoint inhibitors (ICIs)-associated myocarditis remains a rare but fatal adverse event. The authors sought to provide a comprehensive clinical description of ICI-associated myocarditis by analyzing symptoms, laboratory indicators, imaging features, and management of ICI-associ...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yuwen, Chen, Wanwen, Cai, Junying, Luo, Caiyin, Zhou, Chengzhi, Wei, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586979/
https://www.ncbi.nlm.nih.gov/pubmed/37868865
http://dx.doi.org/10.21037/jtd-23-596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586979/
https://www.ncbi.nlm.nih.gov/pubmed/37868865
http://dx.doi.org/10.21037/jtd-23-596

Ejemplares similares